Compare BBD & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBD | IDXX |
|---|---|---|
| Founded | 1943 | 1983 |
| Country | Brazil | United States |
| Employees | 80348 | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2B | 43.6B |
| IPO Year | N/A | 1996 |
| Metric | BBD | IDXX |
|---|---|---|
| Price | $3.44 | $570.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | N/A | ★ $721.67 |
| AVG Volume (30 Days) | ★ 25.6M | 542.4K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.82% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 3.47 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $70.86 | $10.88 |
| Revenue Next Year | $8.33 | $8.59 |
| P/E Ratio | ★ $9.20 | $163.99 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $2.73 | $507.55 |
| 52 Week High | $4.30 | $769.98 |
| Indicator | BBD | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 45.94 | 54.26 |
| Support Level | $3.41 | $567.62 |
| Resistance Level | $3.56 | $587.04 |
| Average True Range (ATR) | 0.08 | 14.46 |
| MACD | 0.02 | 1.38 |
| Stochastic Oscillator | 51.56 | 64.85 |
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.